Cra Financial Services, LLC Eli Lilly & CO Transaction History

Cra Financial Services, LLC

$519 Million
Q3 2024

A detailed history of Cra Financial Services, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cra Financial Services, LLC holds 4,133 shares of LLY stock, worth $3.01 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

4,133

Previous 4,035 2.43%

Holding current value

$3.01 Million

Previous $3.65 Million 0.22%

% of portfolio

0.71%

Previous 0.77%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$772.14 - $960.02 $75,669 - $94,081	98 Added 2.43%	4,133 $3.66 Million
Q2 2024 Jul 11, 2024	BUY	$724.87 - $909.04 $19,571 - $24,544	27 Added 0.67%	4,035 $3.65 Million
Q1 2024 Apr 17, 2024	SELL	$592.2 - $792.28 $49,744 - $66,551	-84 Reduced 2.05%	4,008 $3.12 Million
Q4 2023 Jan 31, 2024	BUY	$525.19 - $619.13 $14,705 - $17,335	28 Added 0.69%	4,092 $2.39 Million
Q3 2023 Oct 13, 2023	SELL	$434.7 - $599.3 $65,205 - $89,895	-150 Reduced 3.56%	4,064 $2.18 Million
Q2 2023 Jul 11, 2023	SELL	$350.74 - $468.98 $12,977 - $17,352	-37 Reduced 0.87%	4,214 $1.98 Million
Q1 2023 Apr 06, 2023	BUY	$310.63 - $364.82 $310 - $364	1 Added 0.02%	4,251 $1.46 Million
Q4 2022 Jan 24, 2023	BUY	$321.55 - $374.67 $964 - $1,124	3 Added 0.07%	4,250 $0
Q3 2022 Oct 21, 2022	SELL	$296.48 - $337.87 $39,431 - $44,936	-133 Reduced 3.04%	4,247 $1.37 Million
Q2 2022 Jul 21, 2022	BUY	$278.73 - $327.27 $1,672 - $1,963	6 Added 0.14%	4,380 $1.42 Million
Q1 2022 Apr 15, 2022	BUY	$234.69 - $291.66 $10,561 - $13,124	45 Added 1.04%	4,374 $1.25 Million
Q3 2021 Oct 12, 2021	BUY	$221.6 - $272.71 $221 - $272	1 Added 0.02%	4,329 $1 Million
Q2 2021 Jul 23, 2021	BUY	$180.55 - $233.54 $180 - $233	1 Added 0.02%	4,328 $993,000
Q1 2021 Apr 16, 2021	BUY	$164.32 - $212.72 $1,807 - $2,339	11 Added 0.25%	4,327 $808,000
Q4 2020 Jan 27, 2021	BUY	$130.46 - $172.63 $6,653 - $8,804	51 Added 1.2%	4,316 $729,000
Q3 2020 Oct 14, 2020	BUY	$146.22 - $169.13 $292 - $338	2 Added 0.05%	4,265 $631,000
Q2 2020 Jul 22, 2020	BUY	$136.42 - $164.18 $136 - $164	1 Added 0.02%	4,263 $700,000
Q1 2020 Apr 14, 2020	BUY	$119.05 - $147.35 $25,833 - $31,974	217 Added 5.36%	4,262 $591,000
Q4 2019 Jan 28, 2020	SELL	$106.92 - $132.43 $1,176 - $1,456	-11 Reduced 0.27%	4,045 $532,000
Q3 2019 Nov 07, 2019	BUY	$106.79 - $116.16 $106 - $116	1 Added 0.02%	4,056 $454,000
Q2 2019 Jul 24, 2019	SELL	$110.79 - $129.32 $55,284 - $64,530	-499 Reduced 10.96%	4,055 $449,000
Q1 2019 Apr 15, 2019	SELL	$111.31 - $131.02 $5,342 - $6,288	-48 Reduced 1.04%	4,554 $591,000
Q4 2018 Feb 08, 2019	BUY	$105.9 - $118.64 $487,351 - $545,981	4,602 New	4,602 $533,000

Others Institutions Holding LLY

# of Institutions

4,002

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $691B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cra Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cra Financial Services, LLC with notifications on news.

Account

Cra Financial Services, LLC Eli Lilly & CO Transaction History